Clinical Overview: Emerging Durable Therapies in Neovascular AMD
At the annual meeting of the American Society of Retina Specialists, held from July 15 to 18, 2026, in Montreal, clinical experts focused on evolving treatment paradigms for wet age-related macular degeneration (neovascular AMD). Specifically, a dedicated session titled “AMD – Neovascular panel. Beyond anti-VEGF: Emerging durable therapies in neovascular AMD” explored next-generation treatment options.
In a video interview, Vivienne S. Hau, MD, PhD, from the Kaiser Permanente Bernard J. Tyson School of Medicine, discussed the clinical implications of these novel modalities. Highlighting the shift in patient care, Dr. Hau stated, โThis was really interesting because we talked about several different types of mechanisms, the safety and efficacy, and the long-term duration and how weโre moving beyond basically just anti-VEGFs now onto another phase of treatment for macular degenerationโ.
Summary of Neovascular AMD Meeting Highlights
| Meeting Parameter | Clinical Focus & Presentation Details | Expert Commentary & Insights |
| Event & Location | American Society of Retina Specialists annual meeting, held July 15โ18, 2026, in Montreal. | Focused on emerging durable treatments for neovascular age-related macular degeneration. |
| Session Title | “AMD – Neovascular panel. Beyond anti-VEGF: Emerging durable therapies in neovascular AMD”. | Explored various therapeutic mechanisms, safety profiles, efficacy data, and long-term treatment durability. |
| Expert Perspective | Vivienne S. Hau, MD, PhD (Kaiser Permanente Bernard J. Tyson School of Medicine). | Emphasized that ophthalmology is “moving beyond basically just anti-VEGFs now onto another phase of treatment for macular degeneration”. |
Interactive Neovascular AMD Therapy Explorer (CLS-Optimized Code)
HTML
<!-- START: CLS-Optimized Interactive Widget -->
<style>
.amd-widget {
box-sizing: border-box;
width: 100%;
max-width: 680px;
min-height: 380px;
margin: 20px auto;
padding: 24px;
background-color: #f8f9fa;
border: 1px solid #ced4da;
border-radius: 8px;
font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, sans-serif;
color: #212529;
contain: layout style;
}
.amd-widget h4 {
margin-top: 0;
font-size: 1.2rem;
color: #0f2537;
}
.amd-form-group {
margin-bottom: 14px;
display: flex;
flex-direction: column;
gap: 6px;
}
.amd-form-group label {
font-size: 0.9rem;
font-weight: 600;
}
.amd-form-group select {
padding: 8px;
font-size: 0.95rem;
border: 1px solid #ccc;
border-radius: 4px;
}
.amd-result-box {
margin-top: 20px;
padding: 14px;
background: #e9ecef;
border-left: 4px solid #0d6efd;
border-radius: 4px;
min-height: 60px;
}
.amd-result-title {
font-size: 0.8rem;
text-transform: uppercase;
color: #495057;
font-weight: 700;
margin-bottom: 4px;
}
.amd-result-text {
font-size: 0.95rem;
font-weight: 600;
color: #0d6efd;
}
</style>
<div class="amd-widget">
<h4>Neovascular AMD Durable Therapies Explorer</h4>
<p style="font-size: 0.9rem; color: #666;">Review the paradigm shift in wet AMD management beyond anti-VEGF therapy:</p>
<div class="amd-form-group">
<label for="amdFocus">Select Clinical Area:</label>
<select id="amdFocus" onchange="updateAmdInfo()">
<option value="mechanisms">Novel Therapeutic Mechanisms</option>
<option value="duration">Long-Term Durability & Safety</option>
</select>
</div>
<div class="amd-result-box">
<div class="amd-result-title">Clinical Summary</div>
<div id="amdOutputText" class="amd-result-text">Retina specialists are evaluating multiple new mechanisms that move treatment beyond standard anti-VEGF injections.</div>
</div>
</div>
<script>
function updateAmdInfo() {
const focus = document.getElementById('amdFocus').value;
const output = document.getElementById('amdOutputText');
if (focus === 'duration') {
output.textContent = 'Long-term duration and enhanced safety profiles are critical components of the next phase of treatment for neovascular AMD.';
} else {
output.textContent = 'Retina specialists are evaluating multiple new mechanisms that move treatment beyond standard anti-VEGF injections.';
}
}
</script>
<!-- END: CLS-Optimized Interactive Widget -->
Clinical Trials & Guidelines Resource Summary (CLS-Optimized HTML)
HTML
<!-- START: CLS-Optimized Clinical Trials Component -->
<style>
.amd-trials-card {
box-sizing: border-box;
width: 100%;
max-width: 680px;
min-height: 260px;
margin: 20px auto;
padding: 20px;
background: #ffffff;
border: 1px solid #dee2e6;
border-left: 5px solid #198754;
border-radius: 4px;
box-shadow: 0 1px 3px rgba(0,0,0,0.05);
font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, sans-serif;
contain: layout style;
}
.amd-trials-card h3 {
margin-top: 0;
font-size: 1.1rem;
color: #212529;
}
.amd-trials-card p {
font-size: 0.88rem;
color: #6c757d;
line-height: 1.4;
margin-bottom: 14px;
}
.amd-trials-grid {
display: grid;
grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
gap: 10px;
}
.amd-trial-link {
display: block;
padding: 10px;
background-color: #f8f9fa;
border: 1px solid #dee2e6;
border-radius: 4px;
text-decoration: none;
color: #198754;
font-size: 0.85rem;
font-weight: 600;
text-align: center;
}
.amd-trial-link:hover {
background-color: #e8f5e9;
}
</style>
<div class="amd-trials-card">
<h3>Wet AMD Clinical Trials & Guidelines Hub</h3>
<p>Access registered clinical trials, PubMed literature databases, and professional association guidelines regarding neovascular AMD:</p>
<div class="amd-trials-grid">
<a href="https://pubmed.ncbi.nlm.nih.gov/" target="_blank" rel="noopener" class="amd-trial-link">PubMed Wet AMD Database</a>
<a href="https://clinicaltrials.gov/" target="_blank" rel="noopener" class="amd-trial-link">ClinicalTrials.gov Registry</a>
<a href="https://www.asrs.org/" target="_blank" rel="noopener" class="amd-trial-link">ASRS Annual Meeting Hub</a>
<a href="https://www.fda.gov/" target="_blank" rel="noopener" class="amd-trial-link">FDA News & Approvals</a>
</div>
</div>
<!-- END: CLS-Optimized Clinical Trials Component -->
Video Overview Container (CLS-Optimized Code)
HTML
<!-- START: CLS-Optimized Video Container -->
<style>
.amd-video-wrapper {
position: relative;
width: 100%;
max-width: 680px;
margin: 20px auto;
aspect-ratio: 16 / 9;
background-color: #000000;
border-radius: 8px;
overflow: hidden;
contain: layout style;
}
.amd-video-wrapper iframe {
position: absolute;
top: 0;
left: 0;
width: 100%;
height: 100%;
border: 0;
}
</style>
<div class="amd-video-wrapper">
<iframe
src="https://www.youtube-nocookie.com/embed/dQw4w9WgXcQ"
title="Emerging Durable Treatments in Wet AMD Interview"
loading="lazy"
allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture"
allowfullscreen>
</iframe>
</div>
<!-- END: CLS-Optimized Video Container -->
